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Pig kidney cells (LLC-PK1) were infected with one of three viruses: wild-type cowpox virus (Brighton red strain) expressing
the crmA gene; recombinant cowpox virus A602, lacking the crmA gene; or cowpox virus A604, a revertant of virus A602,
expressing the crmA gene. The wild-type virus and virus A604 produced identical cytopathic effects consistent with death
by necrosis. In these cells, the structural features of the plasma membrane, the nuclear membrane, and the chromatin
were maintained until lysis of the cells. In contrast, cowpox virus A602 produced cytopathic effects consistent with death
by apoptosis. These effects included loss of microvilli on the cell surface, margination and condensation of the chromatin,
progressive convolution of the nuclear membrane, release of dense chromatin masses on disintegration of the nucleus,
fragmentation of the DNA, and the generation of apoptotic bodies. These results suggest that the crmA gene is necessary
to inhibit processes of apoptosis induced in LLC-PK1 cells by infection with cowpox virus. Thus in cells of certain types,
the crmA gene can act with other viral genes to control the mode of death of the virus-infected cell. This capability may
be advantageous to virus replication in vivo, potentially facilitating both virus trafficking and interference with antiviral
immune defenses. q 1996 Academic Press, Inc.
The cowpox virus crmA gene encodes a serpin that is a variety of cells. Gagliardini et al. (10) demonstrated that
the expression of the crmA gene could prevent cell deatha potent inhibitor of mammalian interleukin-1b con-
verting enzyme (ICE) and other ICE-like cysteine protein- induced by the deprivation of nerve growth factor from
chicken dorsal root ganglion neurons. Boudreau et al.ases (1–4). The CrmA protein is also an inhibitor of gran-
zyme B, a serine proteinase that shares a similar sub- (11) showed that crmA gene expression could inhibit
apoptosis in mammary epithelial cells. The CrmA proteinstrate specificity with ICE (5, 6).
The crmA gene was the first poxvirus gene implicated has also been shown to inhibit apoptosis mediated by
the following: tumor necrosis factor a (12–15); Fas (12,in the direct inhibition of the process of apoptosis. In
1993, Yuan et al. (7) showed that the ced-3 gene, one 14, 16, 17); FADD, a death domain containing protein that
interacts with the death domain of Fas (18); TRADD, aof the genes essential for apoptosis in Caenorhabditis
elegans, encoded a protein sharing significant amino protein that binds to the intracellular domain of the type
I TNF receptor (19); and Yama/CPP32b, a mammalianacid sequence similarity to the precursors of mammalian
ICE. This suggested that ICE, or a similar cysteine pro- homologue of Ced-3, which cleaves poly(ADP-ribose)po-
lymerase (4). These results suggest that the CrmA proteinteinase, might be involved in the induction of apoptosis
in mammalian cells. It also suggested that inhibitors of is capable of inhibiting endogenous ICE-like proteinases
involved in pathways of apoptosis. In addition, the CrmA-ICE, such as the CrmA protein, might inhibit ICE-medi-
ated apoptosis. These predictions were confirmed by mediated inhibition of granzyme B, which is involved in
apoptosis induced by cytotoxic lymphocytes (20–22), in-Miura et al. (8) who showed both that the expression of
the murine ICE in Rat-1 cells led to the induction of dicates that the CrmA protein may be capable of inhib-
iting processes of apoptosis mediated by exogenousapoptosis and that ICE-induced apoptosis could be inhib-
ited by the expression of either the cowpox virus crmA proteinases delivered to a target cell by cytotoxic lympho-
cytes (5). Though as yet, there is evidence only to supportgene or the human bcl-2 gene, an inhibitor of apoptosis
in a number of systems (reviewed in 9). CrmA-mediated inhibition of cytotoxic lymphocyte killing
primarily mediated by Fas ligand (23).The CrmA protein has subsequently been shown to
inhibit apoptosis induced by several different stimuli in These observations suggested that the CrmA protein
might contribute to the inhibition of apoptosis induced in
a cell infected with cowpox virus. Cowpox virus normally1 To whom correspondence and reprint requests should be ad-
dressed. causes the death of infected cells by necrosis, consistent
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with this proposal. Furthermore, evidence that one other pathic effects of cowpox virus replication in cells of sev-
eral types. Wild-type cowpox virus and cowpox virusgene of cowpox virus can function in a this manner was
recently provided by Ink et al. (24), who showed that A602, which lacks the crmA gene, each replicated in
human 143 cells (36), Chinese hamster ovary cells (37),expression of the CHOhr gene, a host-range gene, could
delay the onset of apoptosis in Chinese hamster ovary Rat-1 cells (8), RK13 rabbit kidney cells (38), or LLC-PK1
pig kidney cells (39). In cells of each of these types, thecells infected with vaccinia virus. The importance of this
type of viral countermeasure to this host response is wild-type virus produced cytopathic effects which in-
cluded a change of the cell morphology from an elon-underscored by the fact that DNA-containing viruses of
several families, including the adenoviruses, the herpes- gated spindle-shaped form to a rounded form. These
cytopathic effects were maintained up to 24 hr after infec-viruses, and the baculoviruses, each encode proteins
that can inhibit the induction of apoptosis in virus-in- tion, at which time the cells began to disintegrate. Cow-
pox virus A602 produced cytopathic effects similar tofected cells (25 – 31).
The effects of the crmA gene on modes of cell death those of the wild-type virus in cells of each type except
the LLC-PK1 cells (Fig. 1). In these cells, within 8 hr ofwere examined in the context of infections with either
wild-type cowpox virus (Brighton red strain) or one of two infection, virus A602 produced multiple protuberances
on the surfaces of most if not all the cells. As the infectionrecombinant viruses, a DcrmA cowpox virus (A602) and
a revertant (A604) of this virus. These viruses were con- progressed, the protuberances separated from the cells,
producing spherical or ovoid-shaped bodies that werestructed by standard methods (32), except that precau-
tions were taken to minimize alterations to genetic loci released into the medium. Significantly, these cytopathic
effects were not produced in cells infected with eitherother than the crmA gene. This was done by use of
insertion vectors whose only regions of homology with the original wild-type virus or the revertant virus A604,
demonstrating that these effects, which are characteris-the virus genome were contained within the 1.4-kb NcoI–
HaeIII fragment spanning the crmA gene. This method tic features of cells undergoing apoptosis (reviewed in
40), were the result of the deletion of the crmA gene.prevented the potential replacement of several kilobases
of viral genome with DNA from the plasmid, thereby re- Other characteristic features of apoptosis include the
condensation and margination of the chromatin and theducing the possibility that alterations were introduced
into the viral DNA in addition to those targeted to the indentation of the nuclear membrane. Subsequently, the
lobes of the nucleus fragment into the cytoplasm or intocrmA gene. Accordingly, the DcrmA cowpox virus A602
was made using insertion plasmid p1853, comprising a apoptotic bodies. Effects of these types were also evident
in the LLC-PK1 cells infected with the DcrmA virus A602,2-kb XhoI– BamHI fragment of DNA containing the p7.5/
gpt gene (the Escherichia coli guanosine phosphoribo- but not in cells infected with either the wild-type virus or
the crmA revertant virus A604. Fragmentation of the nu-syltransferase gene under the control of the vaccinia
virus p7.5 promoter) derived from plasmid p1761. Plas- clei of cells infected with virus A602 was most clearly
resolved by electron microscopy of sections of infectedmid p1761 comprises a 2.1-kb EcoRI fragment containing
the p7.5/gpt gene from pTK61-gpt (32) inserted into the cells. Electron microscopy enabled mature and immature
virus particles to be detected in the cytoplasm of eachEcoRI site of pGEM7zf/ (Promega Corp., Madison, WI).
The revertant of virus A602, cowpox virus A604, was cell, providing a means of confirming that virus replica-
tion had occurred in a given cell. Only cells in whichconstructed using insertion vector p1843, comprising the
1.4-kb NcoI– HaeIII fragment spanning the cowpox virus such particles were detected were evaluated for morpho-
logical features resulting from virus replication. SectionscrmA gene, inserted into the EcoRI site of a pUC19 plas-
mid lacking the polylinker region except for the EcoRI through cells harvested 8 hr after infection with the
DcrmA virus A602 showed cells possessing morpholog-and HindIII sites. DNA hybridization analyses (33), using
p1843 as the probe of viral DNAs digested with EcoRI, ies typical of cells undergoing apoptosis (Fig. 2). These
cells had lost the microvilli present on the surface ofPstI, and ClaI, were used to confirm the deletion or rein-
sertion of the crmA gene in the recombinant viruses A602 uninfected cells. They possessed marginated chromatin,
often localized into lobes. With increasing time after in-and A604. Rabbit antibody against the CrmA protein was
used in immunoprecipitation analyses to confirm both fection, their nuclei became more convoluted, progres-
sively degenerating into fragments of chromatin withinthe lack of expression of the crmA gene by virus A602
and the expression of the crmA gene by virus A604. the cytoplasm or within apoptotic bodies. In contrast,
cells infected with either wild-type cowpox virus or theThe infection of the chorioallantoic membranes of chick
embryos, as described (34), confirmed that virus A602 revertant A604 maintained the normal structure of their
nuclei until lysis of the cell. There was no evidence ofproduced the expected white pocks (1, 35), whereas virus
A604 produced red pocks identical to those generated margination of the chromatin, indentation of the nuclei,
fragmentation of the nuclei, or the generation of apoptoticby the wild-type virus (data not shown).
The effects of the crmA gene on cell death during virus bodies, in cells infected with either of these two viruses
at any time after infection.infection were first examined by monitoring the cyto-
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FIG. 1. Expression of the crmA gene affects the morphology LLC-PK1 cells infected with cowpox virus. LLC-PK1 cells were infected with wild-
type cowpox virus, cowpox virus A602 (lacking the crmA gene), or cowpox virus A604 (a revertant of virus A602), at multiplicities of infection of 10
PFU per cell. After 8 hr of incubation at 377, uninfected cells and the virus-infected cells were visualized by phase-contrast microscopy (using a
Zeiss IM35 inverted microscope) and photographed on Kodak TMAX 100.
The quantitative nature of the differences in cytopathic cells containing either fragmented nuclei or membranes
permeable to propidium iodide (Fig. 3). As in other in-effects induced by the three cowpox viruses upon infec-
tion of the LLC-PK1 cells was further demonstrated by stances where apoptosis is induced in a population of
cells (reviewed in 42), apoptosis in the virus-infectedquantifying the proportions of populations of infected
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FIG. 2. LLC-PK1 cells infected with cowpox virus exhibit morphological features associated either with death by necrosis, in the presence of
CrmA protein, or death by apoptosis, in the absence of the CrmA protein. LLC-PK1 cells were left uninfected (a) or infected with wild-type cowpox
virus (b), DcrmA virus A602 (c), or cowpox virus A604 (d), each at multiplicities of infection of 10 PFU per cell. After 8 hr of incubation at 377, the
cells were scraped from their dishes into the media. The cells were recovered by centrifugation (1000 rpm/20 min/47 in a Sorvall H1000B rotor),
fixed in buffer containing 2% glutaraldehyde/0.1 M sodium cacodylate, pH 7.4/3.4% sucrose, and prepared for electron microscopy as described
(41). Briefly, the cells were postfixed in osmium tetroxide and stained in uranyl acetate. The cells were embedded in Spurr resin, and sections were
cut on a Reichert–Jung ultracut E microtome using a diamond knife. Sections were then poststained with uranyl acetate and lead citrate. After
washing, the sections were viewed and photographed in a Jeol 100B electron microscope. Scale bars in each photograph represent 1 mm.
cells occurs asynchronously, perhaps because of the this apoptotic phase. In contrast, fragmented nuclei were
detected in less than 0.3% of cells infected with wild-lack of cell-cycle synchrony among the cells at the time
of viral infection. Nevertheless, marked differences were type cowpox virus, and in less than 0.6% of cells infected
with revertant virus A604. The latter populations of cellsevident among the cell populations, especially by about
12 hr after infection, when most of the cells infected may have been irreversibly committed to apoptosis prior
to infection, because 1.3% of uninfected cells also con-with viruses expressing the crmA gene have become
permeable to propidium iodide. First, cells were stained tained fragmented nuclei. Parenthetically, the percentage
of uninfected cells containing fragmented nuclei maywith DAPI (4*,6-diamindino-2-phenylindole) to detect the
cells passing through the late apoptotic phase of nuclear have been slightly higher than those of the populations
of crmA-expressing virus-infected cells, because only thefragmentation, a phase that occurs prior to disintegration
of the cell. About 16% of the cells infected with cowpox uninfected cells continued to divide and reach conflu-
ency levels capable of inducing contact inhibition of cellvirus A602 (lacking the crmA gene) were going through
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with virus A602 (lacking the crmA gene), both features
which are consistent with the induction of apoptosis in
these cells (reviewed in 43). Whereas, more than 65%
cells infected with either virus expressing the crmA gene
show membrane permeability to propidium iodide with
more than 99% of cells containing unfragmented nuclei,
both features which are consistent with virus-induced
death by necrosis.
Another characteristic feature of cells undergoing
apoptosis is the fragmentation their DNAs, often to frag-
ments whose lengths are in increments of about 180
base pairs. The latter results from intranucleosomal
cleavages (reviewed in 44 and 45). To determine if infec-
tion of LLC-PK1 cells with cowpox virus resulted in the
cleavage of chromosomal DNA, the structures of DNAs
extracted from cells infected with wild-type cowpox virus,
virus A602, or revertant virus A604 were examined. Fig-
ure 4 shows that the chromosomal DNA remains intact
in uninfected cells (lanes a), and in cells infected either
with the wild-type virus (lanes b) or the revertant virusFIG. 3. The membranes of LLC-PK1 cells infected with cowpox vi-
A604 (lanes d), consistent with the lack of morphologicalruses expressing the crmA gene become permeable to propidium io-
dide while maintaining unfragmented nuclei, whereas cells infected changes in the chromatin of these cells. However, DNA
with cowpox virus lacking the crmA gene retain membrane imperme- fragmentation, generating fragments of 2 kilobases or
ability to propidium iodide while their nuclei undergo fragmentation. more, did occur in cells infected with the DcrmA virus
LLC-PK1 cells in preconfluent monolayers were infected with wild-type
A602 (lanes c), consistent with both the margination ofcowpox virus, cowpox virus A602 (lacking the crmA gene), or cowpox
chromatin and the nuclear fragmentation occurring invirus A604 (a revertant of virus A602), at multiplicities of infection of
10 PFU per cell. After 12 hr of incubation at 377, uninfected cells and the these cells. Smaller fragments of chromosomal DNA,
virus-infected cells were stained with either DAPI (final concentration of similar to those produced by actinomycin D treatment of
5 mg/ml) or propidium iodide (final concentration of 5 mg/ml) as de- the cells (lanes e), were not detected in cells infected
scribed (43). Cells were visualized by ultraviolet light and phase-con-
with cowpox virus A602. This shows that DNA fragmenta-trast microscopy (using a Zeiss IM35 inverted microscope). A minimum
tion in the virus-infected cells does not progress to theof 500 cells per sample were analyzed. The bar graphs show the
percentages of cells whose membranes were permeable to propidium extensive intranucleosomal cleavage evident in some
iodide (white bars) and the percentages of cells containing fragmented cells during apoptosis. Similar DNA fragmentation has
nuclei (shaded bars). The bars show means of triplicate infection been described in cells of a number of types during
assays with error bars showing plus and minus one sample standard
apoptosis (44, 46–50).deviation of the data. Error bars are not shown in the instances where
Collectively, the pronounced blebbing of the plasmathe bars are too small to be resolved on the graph.
membrane, the separation of the blebs from the cell sur-
face, the loss of surface microvilli, the preservation of
membrane impermeability to propidium iodide, the mar-division, which renders the cells liable to subsequent
apoptotic cell death. It should also be noted that quantifi- gination of the chromatin, the fragmentation of the nuclei,
and the fragmentation of the chromosomal DNA suggestcation of fragmented nuclei only gives an underestimate
of the total number of cells undergoing apoptosis, be- that LLC-PK1 cells infected with cowpox virus lacking the
crmA gene undergo death by apoptosis. In contrast, cellscause this technique cannot score cells in earlier or later
phases of apoptosis. Second, to assess the status of infected with cowpox virus expressing the crmA gene
display none of these features, suggesting that they un-the cell membranes, cells were stained with propidium
iodide as described (43). Figure 3 shows that only 2.8% dergo death by necrosis. This induction of apoptosis in
cells infected with virus A602 is not the result of expres-of cells infected with cowpox virus A602 were permeable
to propidium iodide, despite extensive cytopathology in sion of the gpt gene that was used to replace the crmA
gene. Infection of LLC-PK1 cells by cowpox virus A555all cells, similar to that depicted in Fig. 1. In contrast,
65% of cells infected with wild-type cowpox virus and (51), in which both copies of the crmB gene have been
replaced by copies of the same p7.5/gpt gene used to71% of cells infected with revertant cowpox virus A604
were permeable to propidium iodide, with all cells exhib- inactivate the crmA gene in virus A602, produced cyto-
pathic effects identical to those of the wild-type cowpoxiting cytopathology (similar to that shown in Fig. 1). Thus
the results of staining with DAPI and with propidium io- virus (data not shown).
The results suggest that the CrmA protein exerts itsdide show the induction of nuclear fragmentation and
the conservation of membrane integrity in cells infected effects on cell death by inhibiting processes of apoptosis
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labeled proteins synthesized in virus-infected PK cells
indicated that the late phase of virus replication begins
about 4 hr postinfection (data not shown), several hours
before cell disruption by either mode of cell death. As
noted above, electron microscopy showed that by 8 hr
after infection immature and mature virus particles were
present in cells infected with either cowpox virus A602
or the wild-type virus. And, as Fig. 3 shows, if necrotic
cell death is assessed by the criterion of membrane per-
meability to propidium iodide, then death in cells infected
with crmA-expressing viruses occurs at about the same
time that the major morphological features of apoptosis
appear in cells infected with cowpox virus A602. Thus
FIG. 4. The DNA of LLC-PK1 cells remains intact during infection for either crmA-minus or crmA-plus viruses the major
with cowpox viruses expressing the crmA gene, but becomes frag-
phases of the virus replication cycle are complete beforemented during infection with cowpox virus lacking the crmA gene. LLC-
the morphological features associated with either end-PK1 cells (1.2 1 106) were either mock-infected or infected with cowpox
virus at a multiplicity of 10 PFU/cell. After 12 hr of incubation at 377, stage apoptosis or necrosis become apparent. Further-
the cells were scraped from the dishes into the media. The cells were more, the sensitivity of cowpox virus and other poxvi-
recovered by centrifugation (1000 rpm/10 min/47 in a Sorvall H1000B ruses to processes of apoptosis may be reduced by the
rotor) and resuspended in 0.3 ml of lysis buffer containing 20 mM
cytoplasmic site of replication of the poxvirus, the limitedHEPES, pH 7.2, 5 mM KCl, 0.5% NP-40, 0.1% sodium deoxycholate,
viral dependence on enzymes encoded by the cell, andand 10 mM EDTA. The suspensions were each divided into two and
incubated on ice for 10 min. Proteinase K (Amersham, Arlington the potential ability of the virus to encode several inhibi-
Heights, IL) was added to each suspension to a final concentration of tors of apoptosis.
0.5 mg/ml, and the suspensions were then incubated at 377 for 2 hr. The LLC-PK1 cells provide an indicator cell in whichResidual protein was removed from each suspension by phenol–chlo-
the antiapoptotic effect of the crmA gene is evident. Inroform extraction. The nucleic acids in each sample were recovered
cells of the other types examined in this study, the lackby ethanol precipitation, and resuspended in 15 ml of TE buffer (10 mM
Tris–HCl, pH 8.0, 1 mM EDTA). RNAs were removed by digestion with of expression of the crmA gene did not result in apoptosis
RNase A (USB, Cleveland, OH) at 377 for 30 min. DNAs in one of of the virus-infected cells. This suggests either that other
the duplicate samples were resolved by electrophoresis through a 2%
agarose gel (left). DNAs in the other duplicate sample were resolved
by electrophoresis through a 0.5% agarose gel (right). Resolved DNAs
TABLE 1were stained with ethidium bromide and visualized by fluorescence
under ultraviolet light. The lanes of the gels contain DNAs of (a) unin-
Effect of crmA Gene Expression Upon the Yield of Progeny Virusfected cells; (b) cells infected with wild-type cowpox virus; (c) cells
from LLC-PK1 Cells Infected with Cowpox Virusinfected with cowpox virus A602 (lacking the crmA gene); (d) cells
infected with cowpox virus A604, the revertant of the A602 virus; and
Titer of virus (PFU/ml) in replicate(e) uninfected cells treated with actinomycin D (1 mg/ml for 24 hr), to
infections (A–C)provide a positive control for apoptosis. Lanes designated (m) contain
Hoursmarker DNAs (lengths indicated in base pairs).
Virus postinfection A B C
CPV-w/ 5 7.8 1 105 7.5 1 105 1.0 1 106
10 8.4 1 106 1.3 1 107 1.5 1 107induced by cowpox virus infection of LLC-PK1 cells. This
24 6.8 1 106 7.3 1 106 7.8 1 106interpretation is consistent with the known properties of
the CrmA protein, which include the abilities to inhibit CPV-A602 5 5.9 1 105 7.7 1 105 6.2 1 105
10 8.5 1 106 8.6 1 106 6.0 1 106apoptosis induced by various stimuli in a variety of cells
24 7.3 1 106 8.6 1 106 7.0 1 106(8, 10–18, 23) and to inhibit ICE and ICE-like enzymes
such as Yama, implicated in the process of apoptosis CPV-A604 5 1.5 1 106 1.4 1 106 1.8 1 106
10 1.5 1 107 1.6 1 107 1.4 1 107(2–4). However, we cannot formally exclude the possibil-
24 1.9 1 107 2.2 1 107 2.2 1 107ity that the crmA gene in some way promotes processes
leading to cell death by necrosis. This might occur in
Note. LLC-PK1 cells were infected with wild-type cowpox virus, cow-addition to CrmA-mediated inhibition of processes lead- pox virus A602, or cowpox virus A604, at multiplicities of 10 PFU/ml.
ing to apoptosis. After 1 hr of incubation at 377 the inoculum was removed, and fresh
medium was added to each culture. At 5, 10, or 24 hr after infectionAlthough apoptosis occurs in LLC-PK1 cells infected
the cells in each culture were scraped into the medium. The cells werewith cowpox virus A602, the yield of progeny virus ob-
then disrupted by freezing, followed by thawing and sonication. Thetained is similar to that obtained during infection of the
titers of virus in each sample were determined by plaque assay on
LLC-PK1 cells with the wild-type virus (Table 1). This find- human 143 cells. Titers of progeny virus were determined from three
ing is consistent with the relative kinetics of virus replica- replicate infections of LLC-PK1 cells with viruses of each of the three
types.tion and death in these cells. Analyses of metabolically
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